APEI AMERICAN PUBLIC EDUCATION INC Insider Trading

325 Capital LLC sells 160,512 shares (160.5K shares) of APEI for $8,726,076.81 over two days at blended average $54.36

325 Capital LLC executed 5 separate sales totaling 160,512 shares for $8,726,076.81 between 2026-03-19 and 2026-03-20, reducing holdings from 996,746 shares to 836,234 shares (a -16.1% reduction). The sales occurred at prices ranging from $53.74 to $55.55, with a blended average of $54.36, near the current price of $55.49. At APEI specifically, the insider has sold on 5 prior occasions within the last year, with two measurable outcomes showing the stock rose 7.8% and 7.1% over 30 days following those earlier sells (and +13.1% and +11.3% over 90 days), indicating prior sells were not well-timed; the insider sold before gains materialized. The cross-ticker track record shows 12 prior sells with a 0.00% well-timed rate overall, meaning all prior sells were followed by gains rather than declines. With annual revenue growth of only +3.9% and a P/E of 21.51, the company's valuation context provides limited support for characterizing this sale as a material confidence signal.

325 Capital LLC sold 184,259 shares of APEI for $10,237,843.53 over 3 days at $55.56 avg, reducing stake 15.6%

325 Capital LLC executed 3 separate sales totaling 184,259 shares for $10,237,843.53 across March 16–18, 2026, at a blended average price of $55.56, reducing holdings from 1.18M to 996.7K shares. The sales occurred while APEI was near its 52-week high of $57.66, having climbed 41.4% over the prior 90 days and 21.8% over the prior 30 days. Notably, 325 Capital's prior 5 sales at APEI generated positive 90-day returns in every case (ranging from 2.9% to 13.1%), with 0 of 5 being well-timed by the metric of selling before subsequent declines. The current stock price of $54.32 sits 5.8% below the 52-week high, within the price window where these recent sales executed. This sale represents the largest single liquidation event in the insider's APEI trade history and occurs at valuations substantially above the stock's baseline, warranting observation of whether subsequent price action aligns with or diverges from the insider's recent disposition.

SVP Axenson sells 20,000 shares for $1.1M at blended average $55.68 in 3 separate transactions

Tanya Joy Axenson, SVP and Chief HR Officer, executed 3 separate sales on 2026-03-16 totaling 20,000 shares (20.0K shares) for $1,113,576.81 ($1.1M), reducing her post-transaction holdings to 49,917 shares (49.9K shares), a decline of 28.6% versus pre-transaction holdings of 69,917 shares (69.9K shares). The sales occurred at prices ranging from $55.20 to $56.90 per share across the three transactions, with a blended average price of $55.68. The current stock price is $55.98, near the 52-week high of $57.66 and representing a 25.5% gain over the 30-day period and 48.6% gain over the 90-day period. The sale represents a material reduction of her position by a significant percentage, though her remaining holdings remain substantial at 49.9K shares. Without disclosure of a prearranged trading plan or additional context around the motivation for these sales, the pattern and timing relative to recent strong momentum warrant investor monitoring of subsequent filings.

325 Capital LLC sells 345,441 shares of APEI for $9,700,926.91 in three trades, reducing stake 22.6%

325 Capital LLC (Director) executed 3 separate sales totaling 345,441 shares (345.4K shares) for $9,700,926.91 on June 4–6, 2025, at prices ranging from $27.96 to $28.21, reducing holdings from 1,526,446 shares to 1,181,005 shares (1.18M shares). The sales occurred while the stock has appreciated 11.2% over 30 days and 20.2% over 90 days, trading at $28.25 current price near the 52-week high of $29.74. The director's cross-ticker track record shows 6 prior sells, though none of those prior sales at APEI have measurable 90-day outcomes; the most recent prior sales at this ticker (May 27–June 3) are themselves very recent and not yet evaluable. The company's fundamentals show $164.6M quarterly revenue, $8.9M net income, 4.0% annual growth, and a 20.77 P/E ratio. This represents a substantial reduction in a director's position during an extended rally.

325 Capital LLC (Director) sold 262,110 shares ($7.7M) over 3 days at avg $29.38; still holds 1,526,446 shares post-transaction.

Director 325 Capital LLC executed 3 separate sales totaling 262,110 shares for $7,701,876.17 between May 30 and June 3, 2025, reducing holdings by 14.7% from 1,788,556 to 1,526,446 shares. The sales occurred at prices ($29.45, $29.33, $29.32) near the stock's current level of $29.14 and well within the 52-week range of $12.30–$29.74. The stock has appreciated 17.4% over 30 days and 43.7% over 90 days from the transaction window. The insider retains a substantial 1,526,446-share position, indicating continued material ownership; the magnitude of the sale relative to pre-transaction holdings is significant but not liquidating. Prior trades at APEI (3 recent sales in late May) remain too recent for meaningful outcome measurement, and the broader cross-ticker track record does not yet establish a pattern specific to APEI's price momentum.

325 Capital LLC sells 134,054 shares of APEI across 3 transactions for $3,976,086.27 at blended avg $29.66

325 Capital LLC, a director at American Public Education Inc, executed 3 separate sales totaling 134,054 shares (134.1K shares) for $3,976,086.27 ($4.0M) on 2025-05-27 and 2025-05-29, reducing holdings from 1,189,066 to 1,055,012 shares (-11.3% vs pre-transaction holdings). The sales occurred at prices ranging from $29.36 to $29.83, near the 52-week high of $29.74, and the stock has appreciated 22.0% over the prior 30 days and 37.5% over the prior 90 days. The filer's cross-ticker track record shows 2 prior buys with a 100.00% 90-day win rate, though this metric reflects cumulative performance across multiple securities rather than predictive insight into APEI specifically. The magnitude and pace of the sale—eliminating 11.3% of the position—represents a material reduction in the director's stake at a price level consistent with recent strength.

Director Michael David Braner bought 17,872 shares of APEI at $16.77 on 2024-08-30; stock now $15.49, -25.1% from 52-week high

Director Michael David Braner purchased 17,872 shares at $16.77, increasing his holdings to 1,922,610 shares. The stock is currently trading at $15.49, down -25.1% from its 52-week high of $20.68, and has declined -10.3% over the past 30 days. This purchase is part of a five-trade sequence within a single week (August 23–30, 2024), with four prior buys at this ticker occurring on consecutive trading days immediately before this filing. APEI's fundamentals show the company was unprofitable over its most recent full fiscal year, with a quarterly net income of $371,000 against revenue of $152,895,000, and annual revenue has contracted -1.0% year-over-year. The magnitude and timing pattern of these purchases merit observation given the stock's recent price weakness and the company's negative earnings backdrop.

Director Michael David Braner bought 20,000 shares of APEI at $16.63 on 2024-08-29; stock now at $16.72, -19.2% from 52-week high.

Braner completed a 20,000-share purchase at $16.63, adding 1.1% to his 1.88M-share position, as the stock trades within 0.5% of the transaction price at $16.72. The buy occurred at a steep discount to the 52-week high of $20.68 and amid a 16.2% pullback over the prior 30 days, yet the company faces structural headwinds: annual revenue declined 1.0%, full-year net income was negative, and the latest quarterly net income was only $371.0K on $152.9M revenue. The director's cross-ticker track record shows 20 prior buys, though measurable outcomes from his five recent APEI purchases remain unavailable. The transaction does not clarify whether this buy reflects conviction in a depressed valuation or simply a disciplined accumulation at a point of price weakness.

Director Braner buys 38,439 shares in 2 transactions for $617,777.17 at APEI, stock -16.2% in 30 days

Director Michael David Braner executed 2 separate purchases totaling 38,439 shares for $617,777.17 at a blended average price of $16.07 on August 27–28, 2024, increasing his holdings from 1,846,299 to 1,884,738 shares (+2.1%). The timing is noteworthy: the stock has declined 16.2% over the 30 days preceding these purchases and is currently trading at $16.55, down 20.0% from its 52-week high of $20.68. Braner has a track record of 20 prior open-market buys across all tickers, though his prior 5 trades at APEI occurred within the same week (August 22–29) and lack sufficient elapsed time for outcome measurement. The company's fundamentals show modest quarterly revenue of $152,895,000.00 and net income of only $371,000.00, with full-year net income negative and annual revenue growth flat at -1.0%, suggesting limited earnings power relative to the 27.58 P/E valuation.

Director Braner Michael David buys 14,393 shares at $15.69; stock down -23.2% from 52-week high of $20.68

Director Braner Michael David acquired 14,393 shares at $15.69 on 2024-08-26, bringing his holdings to 1,846,299 shares post-transaction. The purchase occurs in a period of weakness: the stock is trading at $15.88 currently, down -23.2% from its 52-week high of $20.68 and -18.8% over the past 30 days. At the company level, fundamentals are stressed—the company generated $152,895,000 in latest-quarter revenue but posted only $371,000 in net income, and was unprofitable over its most recent full fiscal year with annual revenue growth of -1.0%. The insider's same-ticker history shows four additional APEI purchases within the preceding days (on 2024-08-28, 2024-08-27, and twice on 2024-08-23, plus one on 2024-08-22), all with outcomes not yet measurable. This cluster of rapid replenishment activity alongside deteriorating profitability and negative price momentum warrants attention to the company's underlying financial trajectory and whether the director possesses material information influencing these purchases.